BACKGROUND: The feasibility of using health system data to estimate prevalence of chronic kidney disease (CKD) stages 3-5 was explored. STUDY DESIGN: Cohort study. SETTING & PARTICIPANTS: A 5% national random sample of patients from the Veterans Affairs (VA) health care system, enrollees in a managed care plan in Michigan (M-CARE), and participants from the 2005-2006 National Health and Nutrition Examination Survey (NHANES). PREDICTOR: Observed CKD prevalence estimates in the health system population were calculated as patients with an available outpatient serum creatinine measurement with estimated glomerular filtration rate <60 mL/min/1.73 m(2), among those with at least one outpatient visit during the year. OUTCOMES & MEASUREMENTS: A logistic regression model was fitted using data from the 2005-2006 NHANES to predict CKD prevalence in those untested for serum creatinine in the health system population, adjusted for demographics and comorbid conditions. Model results then were combined with the observed prevalence in tested patients to derive an overall predicted prevalence of CKD within the health systems. RESULTS: Patients in the VA system were older, had more comorbid conditions, and were more likely to be tested for serum creatinine than those in the M-CARE system. Observed prevalences of CKD stages 3-5 were 15.6% and 0.9% in the VA and M-CARE systems, respectively. Using data from NHANES, the overall predicted prevalences of CKD were 20.4% and 1.6% in the VA and M-CARE systems, respectively. LIMITATIONS: Health system data quality was limited by missing data for laboratory results and race. A single estimated glomerular filtration rate value was used to define CKD, rather than persistence over 3 months. CONCLUSIONS: Estimation of CKD prevalence within health care systems is feasible, but discrepancies between observed and predicted prevalences suggest that this approach is dependent on data availability and quality of information for comorbid conditions, as well as the frequency of testing for CKD in the health care system.
BACKGROUND: The feasibility of using health system data to estimate prevalence of chronic kidney disease (CKD) stages 3-5 was explored. STUDY DESIGN: Cohort study. SETTING & PARTICIPANTS: A 5% national random sample of patients from the Veterans Affairs (VA) health care system, enrollees in a managed care plan in Michigan (M-CARE), and participants from the 2005-2006 National Health and Nutrition Examination Survey (NHANES). PREDICTOR: Observed CKD prevalence estimates in the health system population were calculated as patients with an available outpatient serum creatinine measurement with estimated glomerular filtration rate <60 mL/min/1.73 m(2), among those with at least one outpatient visit during the year. OUTCOMES & MEASUREMENTS: A logistic regression model was fitted using data from the 2005-2006 NHANES to predict CKD prevalence in those untested for serum creatinine in the health system population, adjusted for demographics and comorbid conditions. Model results then were combined with the observed prevalence in tested patients to derive an overall predicted prevalence of CKD within the health systems. RESULTS:Patients in the VA system were older, had more comorbid conditions, and were more likely to be tested for serum creatinine than those in the M-CARE system. Observed prevalences of CKD stages 3-5 were 15.6% and 0.9% in the VA and M-CARE systems, respectively. Using data from NHANES, the overall predicted prevalences of CKD were 20.4% and 1.6% in the VA and M-CARE systems, respectively. LIMITATIONS: Health system data quality was limited by missing data for laboratory results and race. A single estimated glomerular filtration rate value was used to define CKD, rather than persistence over 3 months. CONCLUSIONS: Estimation of CKD prevalence within health care systems is feasible, but discrepancies between observed and predicted prevalences suggest that this approach is dependent on data availability and quality of information for comorbid conditions, as well as the frequency of testing for CKD in the health care system.
Authors: Wolfgang C Winkelmayer; Sebastian Schneeweiss; Helen Mogun; Amanda R Patrick; Jerry Avorn; Daniel H Solomon Journal: Am J Kidney Dis Date: 2005-08 Impact factor: 8.860
Authors: Ann M O'Hare; Daniel Bertenthal; Kenneth E Covinsky; C Seth Landefeld; Saunak Sen; Kala Mehta; Michael A Steinman; Ann Borzecki; Louise C Walter Journal: J Am Soc Nephrol Date: 2006-02-01 Impact factor: 10.121
Authors: Elizabeth F O Kern; Miriam Maney; Donald R Miller; Chin-Lin Tseng; Anjali Tiwari; Mangala Rajan; David Aron; Leonard Pogach Journal: Health Serv Res Date: 2006-04 Impact factor: 3.402
Authors: Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey Journal: JAMA Date: 2007-11-07 Impact factor: 56.272
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Anton C Schoolwerth; Michael M Engelgau; Thomas H Hostetter; Kathy H Rufo; Dolph Chianchiano; William M McClellan; David G Warnock; Frank Vinicor Journal: Prev Chronic Dis Date: 2006-03-15 Impact factor: 2.830
Authors: Subodh J Saggi; Kelly Mercier; Jessica R Gooding; Eli Friedman; Usha Vyas; Natarajan Ranganathan; Pari Ranganathan; Susan McRitchie; Susan Sumner Journal: Int J Probiotics Prebiotics Date: 2017-08-21
Authors: Jorge Arellano; Rohini K Hernandez; Sally W Wade; Kristina Chen; Melissa Pirolli; David Quach; Jane Quigley; Alexander Liede; Vahakn B Shahinian Journal: Cancer Med Date: 2015-02-08 Impact factor: 4.452
Authors: Jill F Lebov; Eliette Valladares; Rodolfo Peña; Edgar M Peña; Scott L Sanoff; Efren Castellón Cisneros; Romulo E Colindres; Douglas R Morgan; Susan L Hogan Journal: Can J Kidney Health Dis Date: 2015-02-24
Authors: Min Xiao; Ajay K Medipally; Laura Biederman; Anjali A Satoskar; Iouri Ivanov; Brad H Rovin; Sergey V Brodsky Journal: Front Med (Lausanne) Date: 2021-11-25
Authors: Jennifer K Carroll; Gerald Pulver; L Miriam Dickinson; Wilson D Pace; Joseph A Vassalotti; Kim S Kimminau; Brian K Manning; Elizabeth W Staton; Chester H Fox Journal: JAMA Netw Open Date: 2018-10-05